Consistent with human genetic findings, liver-specific Tm6sf2-deficient mice show significantly reduced TC and TG levels and VLDL particle size [10,11] while exhibiting spontaneous hepatic steatosis, fibrosis, and accelerated development of hepatocellular cancer [13]. Here, TM6SF2 is linked to hepatocellular carcinoma.